RxSight, Inc. RXST Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77%+5.1pp | 76.6%+5.9pp | 75%+6.5pp | 73.1%+6.9pp | 71.9%+8.5pp | |
| Operating margin | -43.4%-18.6pp | -35.8%-9.5pp | -32%-1.5pp | -28.9%+7.9pp | -24.9%+22.3pp | |
| Net margin | -36.6%-18.7pp | -29%-9.3pp | -25.1%-1.2pp | -21.9%+10.0pp | -17.9%+26.1pp | |
| EBITDA margin | -40.8%-18.1pp | -33.4%-9.6pp | -29.9%-2.7pp | -26.7%+6.5pp | -22.7%+20.3pp | |
| Free cash flow margin | -16.9%-3.1pp | -14.4%+1.6pp | -15.6%+5.6pp | -14.2%+16.5pp | -13.8%+24.9pp | |
| Returns | ||||||
| Return on equity | -17.1%-5.1pp | -14%-1.6pp | -12.9%+1.1pp | -11.7%+5.3pp | -12%+16.8pp | |
| Return on assets | -15.1%-4.4pp | -12.4%-1.4pp | -11.5%+0.9pp | -10.5%+4.2pp | -10.7%+12.4pp | |
| Return on invested capital | -21.1%-2.6pp | -17.7%-0.6pp | -17.2%+1.1pp | -16.6%+2.9pp | -18.6%+11.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×-0.2× | 0.4×-0.1× | 0.5×-0.1× | 0.5×0.0× | 0.6×+0.1× | |
| Inventory turnover | 1×-1.0× | 1.2×-0.9× | 1.4×-0.6× | 1.8×-0.3× | 2×0.0× | |
| Liquidity | ||||||
| Current ratio | 10.2×-2.5× | 10.9×-0.4× | 12.7×+0.1× | 13.9×-0.4× | 12.7×+3.5× | |
| Quick ratio | 8.9×-2.7× | 9.7×-0.8× | 11.4×-0.3× | 12.7×-0.6× | 11.6×+3.5× | |
| Cash ratio | 0.6×-0.6× | 0.8×+0.1× | 1.3×+0.6× | 2×+0.7× | 1.2×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -3,255.7×-1,580× | -2,409.6×-734× | -2,274.2×-413× | -2,025.3×-1,853× | -1,675.5×-1,649× | |
| Per Share | ||||||
| Book value per share | $6.47-6.1% | $6.75-6.7% | $6.74-3.3% | $6.82-4.7% | $6.90+55.0% | |
| Valuation | ||||||
| Market capitalization | $232.23M-56.8% | $428.44M-69.1% | $367.83M-80.6% | $556.73M-74.9% | $1.02B-46.2% | |
| Enterprise value | $225.49M-55.7% | $419.53M-69.6% | $349.77M-81.5% | $528.09M-76.0% | $1.01B-46.2% | |
| Price / sales | 1.8×-1.8× | 3.2×-6.7× | 2.6×-12.2× | 3.8×-15.5× | 6.9×-11.9× | |
| Price / book | 0.9×-1.1× | 1.6×-3.4× | 1.3×-5.5× | 2×-6.1× | 3.7×-7.9× | |
| EV / sales | 1.8×-1.7× | 3.1×-6.8× | 2.5×-12.3× | 3.6×-15.5× | 6.8×-11.7× | |
| Free cash flow yield | -9.3%-5.4pp | -4.5%-2.9pp | -6%-4.6pp | -3.8%-2.2pp | -2%+0.1pp | |
| Earnings yield | -20.1%-14.1pp | -9.1%-7.1pp | -9.7%-8.1pp | -5.8%-4.1pp | -2.6%-0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are RxSight, Inc.'s profit margins?
- RxSight, Inc. (RXST) runs a 77.0% gross margin and a -43.4% operating margin, with a -36.6% net margin.
- Where do RxSight, Inc.'s ratios come from?
- Every ratio is computed from RxSight, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
